Arkanobel Life Sciences Profile
Key Indicators
- Authorised Capital ₹ 0.50 M
as on 24-06-2024
- Paid Up Capital ₹ 0.24 M
as on 24-06-2024
- Company Age 8 Year, 2 Months
- Last Filing with ROC 31 Mar 2021
- Revenue 19.59%
(FY 2020)
- Profit -9.56%
(FY 2020)
- Ebitda 243.34%
(FY 2020)
- Net Worth 77.04%
(FY 2020)
- Total Assets 117.25%
(FY 2020)
About Arkanobel Life Sciences
The Corporate was formerly known as Arkas Therapeutics Private Limited. The Company is engaged in the Trading Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2021. It's a company limited by shares with an authorized capital of Rs 0.50 M and a paid-up capital of Rs 0.24 M, as per Ministry of Corporate Affairs (MCA) records.
Tapas Dutta, Bikram Chakraborty, Chandrashekhar Sahu, and One other member serve as directors at the Company.
- CIN/LLPIN
U51909CT2016PTC007579
- Company No.
007579
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
13 Oct 2016
- Date of AGM
27 Dec 2021
- Date of Balance Sheet
31 Mar 2021
- Listing Status
Unlisted
- ROC Code
Roc Chhattisgarh
Industry
Company Details
- Location
Bilaspur, Chattisgarh, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Arkanobel Life Sciences?
Board Members(4)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Tapas Dutta  | Director | 26-Nov-2021 | Current |
| Bikram Chakraborty | Additional Director | 05-Jun-2022 | Current |
| Chandrashekhar Sahu | Additional Director | Current | |
| Aditya Lal | Director | 26-Nov-2021 | Current |
Financial Performance of Arkanobel Life Sciences.
Arkanobel Life Sciences Private Limited, for the financial year ended 2020, experienced significant growth in revenue, with a 19.59% increase. The company also saw a slight decrease in profitability, with a 9.56% decrease in profit. The company's net worth Soared by an impressive increase of 77.04%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Arkanobel Life Sciences?
In 2017, Arkanobel Life Sciences had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
- Cv Infrastructure And Solution Private LimitedActive 1 year 6 months
Chandrashekhar Sahu is a mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Arkanobel Life Sciences?
Unlock and access historical data on people associated with Arkanobel Life Sciences, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Arkanobel Life Sciences, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Arkanobel Life Sciences's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
